Guidelines were informed by the NIH-supported REPRIEVE trial

Thursday, February 29, 2024 New Guidelines for Use of Statins by People with HIV to Prevent Cardiovascular Events ClinicalInfo.HIV.gov is provided in collaboration with NIH's Office of AIDS Research Credit: HIV.gov The Department of Health and Human Services Guidelines Panel for the Use of Antiretroviral Agents in Adults and Adolescents with HIV has developed recommendations for the use of statin therapy in people with HIV, in collaboration with representatives from the American College of Cardiology, the American Heart Association, and the HIV Medicine Association. The new guidelines were informed by findings from the NIH-supported Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE) trial. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).                             This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107